These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 3927648

  • 1. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL, Wersäll J, Werner S.
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW, Verleun T, Oosterom R.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [Abstract] [Full Text] [Related]

  • 6. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth hormone and prolactin in tissue culture of pituitary adenoma.
    Demura R, Kubo O, Odagiri E, Nomura K, Yamaguchi H.
    Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A, Murabe H, Nakamura Y, Mizuta H, Ihara C, Nakao K.
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells.
    Escobar DC, Vicentini LM, Ghigo E, Ciccarelli E, Usellini L, Capella C, Cocchi D.
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):345-50. PubMed ID: 3019052
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas.
    Serri O, Somma M, Rasio E, Brazeau P.
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):65-75. PubMed ID: 2505955
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
    Natori S, Ikuyama S, Haji M, Ohashi M, Nawata H.
    Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.
    Lopes MB, Gaylinn BD, Thorner MO, Stoler MH.
    Am J Pathol; 1997 Jun; 150(6):1885-91. PubMed ID: 9176381
    [Abstract] [Full Text] [Related]

  • 15. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K, Yamaji T, Yamashita K.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [Abstract] [Full Text] [Related]

  • 16. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
    Felix I, Asa SL, Kovacs K, Horvath E, Smyth HS.
    Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
    [Abstract] [Full Text] [Related]

  • 17. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H, Refetoff S, Fang VS.
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [Abstract] [Full Text] [Related]

  • 18. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K, Arai K, Sanno N, Teramoto A, Shibasaki T.
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [Abstract] [Full Text] [Related]

  • 19. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
    Spada A, Elahi FR, Arosio M, Sartorio A, Guglielmino L, Vallar L, Faglia G.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
    [Abstract] [Full Text] [Related]

  • 20. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.